Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
10.99
-0.10 (-0.90%)
Dec 23, 2024, 4:00 PM EST

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of 24.90 billion. The enterprise value is 27.94 billion.

Market Cap 24.90B
Enterprise Value 27.94B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date Feb 4, 2025
Ex-Dividend Date Dec 9, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +4.36%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 141.36M

Valuation Ratios

The trailing PE ratio is 32.95.

PE Ratio 32.95
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.64, with an EV/FCF ratio of 116.77.

EV / Earnings 36.98
EV / Sales 7.41
EV / EBITDA 23.64
EV / EBIT 27.42
EV / FCF 116.77

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.

Current Ratio 1.02
Quick Ratio 0.62
Debt / Equity 1.26
Debt / EBITDA 2.67
Debt / FCF 14.14
Interest Coverage 9.19

Financial Efficiency

Return on equity (ROE) is 28.67% and return on invested capital (ROIC) is 11.80%.

Return on Equity (ROE) 28.67%
Return on Assets (ROA) 9.49%
Return on Capital (ROIC) 11.80%
Revenue Per Employee 242,964
Profits Per Employee 45,411
Employee Count 16,639
Asset Turnover 0.56
Inventory Turnover 2.44

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.77% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -4.77%
50-Day Moving Average 12.47
200-Day Moving Average 12.83
Relative Strength Index (RSI) 28.36
Average Volume (20 Days) 206,437

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Coloplast had revenue of 4.04 billion and earned 755.59 million in profits. Earnings per share was 3.36.

Revenue 4.04B
Gross Profit 2.73B
Operating Income 1.09B
Pretax Income 956.45M
Net Income 755.59M
EBITDA 1.23B
EBIT 1.09B
Earnings Per Share (EPS) 3.36
Full Income Statement

Balance Sheet

The company has 117.86 million in cash and 3.38 billion in debt, giving a net cash position of -3.27 billion.

Cash & Cash Equivalents 117.86M
Total Debt 3.38B
Net Cash -3.27B
Net Cash Per Share n/a
Equity (Book Value) 2.68B
Book Value Per Share 11.92
Working Capital 35.90M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 413.69 million and capital expenditures -174.39 million, giving a free cash flow of 239.30 million.

Operating Cash Flow 413.69M
Capital Expenditures -174.39M
Free Cash Flow 239.30M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.59%, with operating and profit margins of 27.04% and 18.69%.

Gross Margin 67.59%
Operating Margin 27.04%
Pretax Margin 23.66%
Profit Margin 18.69%
EBITDA Margin 30.30%
EBIT Margin 27.04%
FCF Margin 5.92%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.77%.

Dividend Per Share 0.20
Dividend Yield 1.77%
Dividend Growth (YoY) 3.01%
Years of Dividend Growth 1
Payout Ratio 93.43%
Buyback Yield -4.36%
Shareholder Yield -2.59%
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Coloplast has an Altman Z-Score of 5.4.

Altman Z-Score 5.4
Piotroski F-Score n/a